Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-10

Clinical Trial Update: Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updates show results for using ketamine to rapidly treat Major Depressive Disorder and Alcohol Use Disorder, with completed status and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-10